B cell non-Hodgkin lymphoma | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

108,546 results for “B cell non-Hodgkin lymphoma”

Trials

View all 77498 →

Study of Relapsed/ Refractory B-cell Non- Hodgkin Lymphoma

20 participants · First posted Aug 15, 2025

Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma

80 participants · First posted Nov 7, 2022

Not yet recruiting

JWCAR239 in Patients With B Cell Non-Hodgkin Lymphoma

20 participants · First posted Jun 17, 2025

Drugs

View all 7093 →

anti-CD19 CAR T-cell therapy (B-cell non-Hodgkin lymphoma)

bispecific CD19/CD22 CAR T-cell therapy ( relapsed/refractory B-cell Non-Hodgkin Lymphoma)

Investigational

Odronextamab(Ordspono)

Organizations

View all 3326 →

AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP

Australia

AB&B BIO-TECH-B

Gamida Cell

Israel

News

View all 20629 →

Artiva's AlloNK Shows Promising Durability in B-Cell Non-Hodgkin Lymphoma, Matching CAR-T Efficacy

Iksuda Therapeutics Initiates First-in-Human Trial of CD19-Targeted ADC IKS03 for Advanced B-Cell Non-Hodgkin Lymphoma

Daiichi Sankyo Initiates First-in-Human Trial of DS3790, Novel CD37-Targeted ADC for B-Cell Lymphoma

Page 1 of 10855